| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Alpna Seth is Director at TECH and has filed Form 4s across 2 companies. Alpna Seth's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.4M at current prices.
The biggest single holding is TECH (~$1.3M) as Director. The TECH filings lean toward selling, a net 5,023 shares.
Alpna Seth has 17 Form 4 filings on record from October 2017 to October 2026, across 2 companies: Director at Bio-Techne (TECH), 2017–2026; Director at Keros Therapeutics (KROS), 2023–2026.
The 31 reported transactions were 14 option or other derivative awards, 12 stock awards, 3 open-market sales and 2 option exercises.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $1.6M.
The largest open-market sale was 5,023 shares of TECH at an average $306.62 on November 9, 2020, about $1.5M.